Optimization of TLC method for separation and determination of ziprasidone and its impurities

References

• Lemke, T. L.; Williams, D. A.; Roche, V. F.; Zito, S. W. Foye’s Principles of Medicinal Chemistry, 7th edn, Lippincott Williams & Wilkins: Baltimore, 2012, 449–484.
   Google Scholar
• Greenberg, W. M.; Citrome, L. Ziprasidone for Schizophrenia and Bipolar Disorder: A Review of the Clinical Trials. CNS Drug Rev. 2007, 13, 137–177.
   PubMedGoogle Scholar
• Farina, C.; Kremser, L.; Raggi, M. A.; Kenndler E. Determination of Ziprasidone in Pharmaceutical Formulations by Capillary Zone Electrophoresis. J. Pharm. Biomed. Anal. 2008, 46, 471–476.
   PubMed Web of Science ®Google Scholar
• Skibinski, R.; Komsta, L. Validation of NP-HPTLC and RP-HPTLC Methods with Videodensitometric Detection for Analysis of Ziprasidone in Pharmaceutical Formulations. J. Planar. Chromatogr. Mod. TLC 2010, 23, 23–27.
   Web of Science ®Google Scholar
• Pavlovic, M.; Malesevic, M.; Nikolic, K.; Agbaba, D. Development and Validation of an HPLC Method for Determination of Ziprasidone and its Impurities in Pharmaceutical Dosage Forms. J. AOAC Int. 2011, 94, 713–722.
   PubMed Web of Science ®Google Scholar
• Singh, A.; Rao, B. M.; Desphie, G. R.; Sangaraju, S.; Srinivasu, M. K.; Devi, M. L.; Satyanarayana, P. V. V.; Chirasekhar, K. B. A Rapid Stability-Indicating LC Method for Ziprasidone Hydrochloride. Chromatographia 2007, 65, 191–196.
   Web of Science ®Google Scholar
• El-Sherif, Z. A.; El-Zeany, B.; El-Houssini, O. M.; Rashed, M. S.; Aboul-Enein, H. Y. Stability Indicating Reversed-Phase High-Performance Liquid Chromatographic and Thin Layer Densitometric Methods for the Determination of Ziprasidone in Bulk Powder and in Pharmaceutical Formulations. Biomed. Chromatogr. 2004, 18, 143–149.
   PubMed Web of Science ®Google Scholar
• Zakowiecki, D.; Cal, K. Development of Rapid and Robust Stability-Indicating Method for Analysis of Ziprasidone (Hydrochloride and Freebase) as Drug Substance and in Medicines by UPLC. Acta Pol. Pharm. Drug Res. 2012, 69, 809–819.
   PubMed Web of Science ®Google Scholar
• Ray, S.; Kumari, S. K.; Krishnaiah, C.; Rao, N. A. Development of a Stability-Indicating UPLC Method for Determination Ziprasidone Hydrochloride and its Associated Degradation Products Present in Active Pharmaceutical Ingre and Pharmaceutical Dosage Forms. J. Liq. Chromatogr. Relat. Technol. 2013, 36, 968–982.
   Web of Science ®Google Scholar
• Mohamed, I.; Belal, W. F., El-Enany, N.; Eid, M.; El-Shaheny, R. N. Stability-Indicating Spectrofluorimetric Method for the Assay of Ziprasidone in Capsules. J. Fluoresc. 2011, 21, 1659–1667.
   PubMed Web of Science ®Google Scholar
• Li, M. Organic Chemistry of Drug Degradation; RSC Publishing: Cambridge, UK, 2012; 124–126.
   Google Scholar
• Hong, J.; Shah, J. C.; Mcgonagle, M. D. Effect of Cyclodextrin Derivation and Amorphous State of Complex on Accelerated Degradation of Ziprasidone. J. Pharm. Sci. 2011, 100, 2703–2716.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia, 8th edn. Council of Europe: Strasbourg, France, 2014.
   Google Scholar
• United States Pharmacopoeia, 38NF-33; US Pharmacopeia Convention: Rockville, MD, 2015.
   Google Scholar
• Skibinski, R. Photostability Study and Identification of Photodegradation Products of Ziprasidone by UHPLC-DAD/ESI-Q-TOF. J. Liq. Chromatogr. Relat. Technol. 2012, 35, 2097–2012.
   Web of Science ®Google Scholar
• Sharp, T. R.; Leeman, K. R.; Bryant, D. E.; Horan, G. J. On the Photoisomerization of the Benzisothiazole Portion of Ziprasidone. Tetrahedron Lett. 2003, 44, 1559–1561.
   Web of Science ®Google Scholar
• Nikolic, K.; Pavlovic, M.; Smoliński, A.; Agbaba, D. The Chemometric Study and Quantitative Structure Retention Relationship Modeling of Liquid Chromatography Separation of Ziprasidone Components. Comb. Chem. High Throughput Screening 2012, 15, 730–744.
   PubMed Web of Science ®Google Scholar
• Directive 1999/45/EC of the European Parliament and of the Council. Official J. 1999, 200, 1–68.
   Google Scholar
• Ferenczi-Fodor, K.; Vegh, Z.; Nagy-Turak, A.; Renger, B.; Zeller, M. J. Validation and Quality Assurance of Planar Chromatographic Procedures in Pharmaceutical Analysis. J. AOAC Int. 2001, 84, 1265–1276.
   PubMed Web of Science ®Google Scholar
• ICH Harmonized Guideline: Validation of Analytical Procedures: Text and Methodology Q (R1); Geneva, 2005.
   Google Scholar
• Renger, B.; Végh, Z.; Ferenczi-Fodor, K. Validation of Thin Layer and High Performance Thin Layer Chromatographic Methods. J. Chromatogr. A 2011, 13, 2712–2721.
   Web of Science ®Google Scholar